EBX 102
Alternative Names: EBX-102Latest Information Update: 29 Apr 2024
At a glance
- Originator EnteroBiotix
- Class Bacteria
- Mechanism of Action Bacteria replacements; Gastrointestinal microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Liver cirrhosis